Section Editors

Marc Peeters - Head of the oncology department at the Antwerp University Hospital, Coordinator of the Multidisciplinary Oncology Center Antwerp, Chairman of the College of Oncology.

Marc Peeters

Head of the oncology department at the Antwerp University Hospital, Coordinator of the Multidisciplinary Oncology Center Antwerp, Chairman of the College of Oncology.

Marc Peeters is Professor of oncology at the Antwerp University, Belgium. He is head of the oncology department at the Antwerp University Hospital and coordinator of the Multidisciplinary Oncology Center Antwerp. He is also chairman of the College of Oncology. Previously, he was Coordinator of the Digestive Oncology Unit at the University Hospital in Ghent, Belgium. He completed his medical studies at the Catholic University in Leuven, Belgium and his training in Internal Medicine at the UZ Gasthuisberg in Leuven. He underwent additional training in Oncology and Digestive Oncology at the UZ Gasthuisberg, the Institut Gustave Roussy in Villejuif – Paris, the University of Pennsylvania Hospital in Philadelphia, the Royal Marsden Hospital in London, and the Memorial Sloan-Kettering Cancer Center in New York.

Dr. Peeters is Secretary of the Flemish Society of Gastroenterology. He is treasurer of the Belgian Group of Digestive Oncology and member of the Belgian Society of Medical Oncology, The European Society of Medical Oncology, The American Society for Clinical Oncology and the gastrointestinal group of the European Organisation for Research and Treatment of Cancer.

His research interests have included the identification of molecular markers and therapy modulation in digestive tumours. He has been involved in many clinical studies on therapeutic agents for gastrointestinal tumours. He published numerous articles in peer reviewed journals and was author of several chapters in oncology books.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Dr Marc Peeters, from our European Editorial Board, discusses the left/right position of colon cancer and how this affects prognosis and treatment. FILMED AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING, OCTOBER 2016.
Arthur Sun Myint - Filmed at the NCRI 2015, Liverpool. Part 2/4: Arthur Sun Myint discusses the recent NICE recommendation of the Papillion treatment.
Dr. Howard Hochster from the Yale Cancer Center in New Haven discusses the importance of genetic testing for expanded RAS mutations, to include all KRAS and NRAS, in patients with metastatic colorectal cancer.

Gastrointestinal Oncology INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Insight
New Study Recommends Pancreatic Cancer Screening for High-risk Patients Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK